The French and Italian authorities have stopped vaccination against coronavirus with a drug from the British company AstraZeneca. Reuters news agency reports.
Earlier on the same day, it became known about the same decision of the German Ministry of Health, before that a number of other EU countries refused the vaccine. The FRG stressed that the decision is not in any way political.
Earlier, the British-Swedish company AstraZeneca announced the safety of its coronavirus vaccine. The company explained that a detailed study of the health status of more than 17 million people vaccinated in the European Union (EU) and the UK with the coronavirus drug showed no data on an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia.
Austria, Estonia, Latvia, Lithuania and Luxembourg have stopped using the drug from a specific batch of one million doses, which was supplied to 17 European countries. At the same time, Denmark, Iceland and Norway have stopped all their supplies of this vaccine. According to the EMA, 22 cases of thrombosis were recorded in the EU by March 12 per three million AstraZeneca vaccinated. The regulator does not link this phenomenon with the use of the vaccine, but the investigation of deaths continues.